Japan Ovarian Cancer Market Size & Outlook, 2025-2033


Japan Ovarian Cancer Market Insights

  • As per Reed Intelligence insights, the Japan Ovarian Cancer Market stood at USD 31.76 Million in 2024 and is anticipated to grow to USD 222.79 Million by 2033.
  • The Japan market is expected to advance at a CAGR of 24.18% from 2026 through 2033.
  • In 2024, Epithelial Tumors accounted for the highest share of the By Type market size.
  • During the forecast period, Germ Cell Tumors is set to register the highest growth, making it the most lucrative By Type segment.

Other Key Findings


  • In 2024, Japan accounted for 2.35% of the global Ovarian Cancer Market size.
  • By 2033, United States is expected to lead the global Ovarian Cancer Market in terms of market size.
  • Within Asia Pacific, China is projected to dominate the regional Ovarian Cancer Market size by 2033.
  • Australia is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 90.37 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 31.76 Million
Market Size In 2033 USD 222.79 Million
Largest segment Epithelial Tumors
Units Revenue in USD Million
CAGR 24.18% (2025-2033)
Segmnetation Covered
By Type
  1. Epithelial Tumors
  2. Germ Cell Tumors
  3. Stromal Tumors
  4. Primary Peritoneal Cancer
By Diagnosis
  1. Computed Tomography (C.T.) Scans
  2. Ultrasound
  3. Barium Enema X-Ray
  4. Magnetic Resonance Imaging (MRI) Scans
  5. Chest X-Ray
  6. Positron Emission Tomography (PET) Scan
  7. Other Diagnostic Tests
By Therapeutic Treatment
  1. Chemotherapy
  2. Radiation Therapy
  3. Targeted Therapy
  4. Hormone Therapy
  5. Other Therapeutic Treatments
  6. Surgery
By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
By Drugs
  1. Mitotic Inhibitors
  2. Antirheumatics
  3. Antipsoriatics
  4. VEGF/VEGFR inhibitors
  5. PARP inhibitors
  6. Antineoplastics
  7. Others
By End-User
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends